Ketone– tag –
-
UC San Diego Unveils World’s First Fully Integrated Smart Ring for Simultaneous, Continuous Sweat-Based Tracking of Multiple Biomarkers Including Glucose, Ketones, and Vitamin C
UC San Diego Today USA Overview Engineers at UC San Diego have unveiled the world's first fully integrated smart ring capable of simultaneously and continuously tracking multiple biomarkers from sweat, including glucose, ketones, vitamin... -
Wearable and Implantable Biosensors Advance Beyond Glucose to Continuous Monitoring of Metabolic, Hormonal, and Inflammatory Biomarkers
Frontiers in Bioengineering and Biotechnology Switzerland Overview Wearable and implantable biosensors are undergoing a paradigm shift, moving beyond continuous glucose monitoring to encompass comprehensive real-time tracking of diverse ... -
ADA 2026: CGM Applications Expand to Type 2 Diabetes; Continuous Ketone Monitoring and Dual Sensors Advance DKA Prevention
Pharmacy Times USA Overview The 86th American Diabetes Association (ADA) Scientific Sessions in 2026 highlighted a significant expansion of continuous glucose monitoring (CGM) beyond intensive insulin management to a broader Type 2 diabe... -
CNET Names Dexcom Stelo, Abbott FreeStyle Libre 3 Plus, and Eversense 365 as Top Continuous Glucose Monitors for 2026, Setting New Standards in Blood Sugar Management
CNET USA Overview CNET's 2026 review identifies Dexcom Stelo, Abbott FreeStyle Libre 3 Plus, and Eversense 365 as leading continuous glucose monitoring (CGM) devices. These systems excel in sensor life, accuracy, and FDA approval status,... -
Dorsey & Whitney Trust CO LLC Sells Abbott Laboratories Shares Amidst Focus on Libre Duo CE Mark Approval
MarketBeat USA Overview Dorsey & Whitney Trust CO LLC has reduced its holdings in Abbott Laboratories shares. Despite this divestment, Abbott is gaining significant attention for its recent CE Mark approval of Libre Duo, an innovativ... -
Erste Group Bank Adjusts Abbott’s FY2027 Earnings Outlook Downward, Highlights Libre Duo CE Mark as Key Growth Driver
MarketBeat USA Overview Erste Group Bank has slightly lowered its fiscal year 2027 earnings outlook for Abbott Laboratories, yet emphasizes Abbott's recent CE Mark approval for its innovative Libre Duo dual glucose-ketone sensing technol... -
Abbott Secures CE Mark for World’s First Dual Glucose-Ketone Sensor, Revolutionizing DKA Management
MedTech Dive USA Overview Abbott has received European CE Mark approval for its Libre Duo and Libre Duo 10 Day systems, the world's first dual-analyte sensors capable of continuously measuring both glucose and ketones. This technology ai... -
Microneedle Sensor Promises Painless, Continuous Monitoring of Ketone and Glucose for Early DKA Detection
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) USA Overview Supported by NIDDK, an innovative microneedle sensor is under development for the early detection and management of Diabetic Ketoacidosis (DKA). This e...
